[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100149453":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":29,"centralContacts":28,"locations":33,"responsibleParty":71,"collaborators":28,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":75,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":28,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":93,"overallStatus":97,"whyStopped":28,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Cytori Therapeutics","INDUSTRY",[8,13],{"label":9,"type":10,"description":9,"interventionNames":11},"Dose A","ACTIVE_COMPARATOR",[12],"Biological: Dose A",{"label":14,"type":15,"description":14,"interventionNames":16},"Placebo","PLACEBO_COMPARATOR",[17],"Biological: Placebo",[19,25],{"type":20,"name":9,"description":21,"armGroupLabels":22,"otherNames":23},"BIOLOGICAL","ADRC Dose A",[9],[24],"Adipose-Derived Regenerative Cells",{"type":20,"name":14,"description":26,"armGroupLabels":27,"otherNames":28},"Placebo Comparator",[14],null,[30],{"name":31,"affiliation":5,"role":32},"Steven Kesten, MD","STUDY_DIRECTOR",[34,45,56,62],{"facility":35,"status":28,"city":36,"state":28,"zip":28,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":28},"Erasmus University Medical Centrum","Rotterdam","Netherlands","NL",{"type":40,"coordinates":41},"Point",[42,43],4.47917,51.9225,{"lat":43,"lon":42},{"facility":46,"status":28,"city":47,"state":28,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":55,"contacts":28},"Krakowski Szpital Specjalistyczny im. Jana Pawla II Oddzial Kliniczny Chorob Serca i Naczyn","Krakow","31202","Poland","PL",{"type":40,"coordinates":52},[53,54],19.93658,50.06143,{"lat":54,"lon":53},{"facility":57,"status":28,"city":47,"state":28,"zip":58,"country":49,"countryCode":50,"cosmosGeoPoint":59,"geoPoint":61,"contacts":28},"Szpital Uniwersytecki Samodzielna Pracownia Zakladu Hemodynamiki","31501",{"type":40,"coordinates":60},[53,54],{"lat":54,"lon":53},{"facility":63,"status":28,"city":64,"state":28,"zip":65,"country":49,"countryCode":50,"cosmosGeoPoint":66,"geoPoint":70,"contacts":28},"Samodzielny Publiczny Centralny Szpital Kliniczny Pracownia Kardiologii Inwazyjnej","Warsaw","02097",{"type":40,"coordinates":67},[68,69],21.01178,52.22977,{"lat":69,"lon":68},{"type":72,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR","100149453","phase-2-safety-and-efficacy-of-adipose-derived-regenerative-cells-adrcs-delivered-via-the-intracoronary-route-in-the-treatment-of-patients-with-st-elevation-acute-myocardial-infarction-ami-100149453",false,"NCT01216995","Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI)","A Phase II Trial of Safety and Efficacy of ADRCs Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction - The ADVANCE Study","ADVANCE","Key Inclusion Criteria:\n\n* ST-segment Elevation Myocardial Infarction (STEMI) Criteria:\n* Ischemic symptoms AND\n* ECG:\n* Development of pathologic Q waves on the ECG; or\n* ECG changes indicative of severe ischemia (ST segment elevation and\u002For depression); or\n* New left bundle branch block; AND\n* Creatine Phosphokinase Isoenzyme (MB Form) \\> 100 IU\u002FL, or troponin \\>5x the upper limit of normal between admission and randomization\n* Successful revascularization of the culprit lesion in a major epicardial vessel\n\nKey Exclusion Criteria:\n\n* More than 24 hours between PCI and start of liposuction\n* Prior myocardial infarction, cardiomyopathy, or a history of congestive heart failure\n* Pacemaker, ICD, or any other contra-indication for MRI\n* Patients with increased bleeding risk\n* Cardiogenic shock present post-index PCI","ALL","20 Years","80 Years",{"count":85,"type":86},23,"ACTUAL","INTERVENTIONAL",[89],"PHASE2","Double blind, prospective, randomized, placebo-controlled Safety and Efficacy trial of ADRCs delivered via the intracoronary route in the treatment of patients with ST-elevation acute myocardial infarction (STEMI).",[92],"Acute Myocardial Infarction",[94,95,96],"Heart Attack","Regenerative Cells","Stem Cells","COMPLETED","2014-11-19",{"date":100,"type":101},"2014-11-21","ESTIMATED",{"date":103,"type":28},"2012-09",{"date":105,"type":86},"2014-05",{"name":5,"class":6},4]